Bosnia and Herzegovina vs Pakistan: New cases tested for RR-/MDR-TB
Bosnia and Herzegovina
74.0%
in 2024
Pakistan
77.0%
in 2024
Bosnia and Herzegovina rank
135th
Pakistan rank
132nd
New cases tested for RR-/MDR-TB over time
- Bosnia and Herzegovina
- Pakistan
How they compare
Pakistan currently reports 77.0% against 74.0% in Bosnia and Herzegovina, a difference of 3.0%.
The two have swapped places 1 time across 16 shared years of data; in 2008 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 135th and Pakistan ranks 132nd of 192 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.1% | 99.9% | Bosnia and Herzegovina |
| 2010s | 97.7% | 16.6% | 81.0% | Bosnia and Herzegovina |
| 2020s | 93.0% | 73.2% | 19.8% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Bosnia and Herzegovina or Pakistan?
- Pakistan, at 77.0% against 74.0% in Bosnia and Herzegovina as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Bosnia and Herzegovina and Pakistan?
- 3.0%, with Pakistan ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Pakistan?
- 16 years are reported by both, from 2008 to 2024.
- How do Bosnia and Herzegovina and Pakistan rank globally for new cases tested for rr-/mdr-tb?
- Bosnia and Herzegovina ranks 135th and Pakistan ranks 132nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.